CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Metatypical basal cell carcinoma: a clinical review
Authors
A Bogdanov-Berezovsky
A Bucur
+59 more
A Chu
A Sari
A Tosca
AB Fleischer Jr
Annamaria Corbianco
AW Wilson
B Niederhagen
C Gall
CC Huang
D Labbe
Daniele Innocenzi
DE Rowe
DE Rowe
DG Brodland
DJ Wolf
DP Goldberg
E Epstein
E Tavin
EA Konrad
Emanuele Cigna
GG Hallock
HZ Lund
I Leibovitch
IA Kazantseva
IA Kazantseva
IA Kazantseva
J Barry
JD Hsuan
JD Seidman
JD Seidman
JL de Faria
JS Reis-Filho
LM Dzubow
M Zak-Prelich
MA Weinstock
Mauro Tarallo
Nicolò Scuderi
NWJ Smeets
O Hirschsteiner
PE Swanson
PG Lang
PH Bowman
R Bianchini
RE Kwa
RG Mora
Riccardo Frati
RM Halder
RM Halder
RW Griffiths
RW Griffiths
RW Griffiths a
Sergio Delfino
SJ Miller
SS Strom
TL Barrett
TL Diepgen
TS Housman
Umberto Fama
VG Khurana
Publication date
1 January 2008
Publisher
BioMed Central
Doi
Cite
View
on
PubMed
Abstract
Background. Metatypical cell carcinoma can be considered as a new entity of skin cancer, being an intermediate typology between basal cell carcinomas and squamous cell carcinomas. The behaviour of the metatypical cell carcinoma lies between these two varieties of skin cancer. It is difficult to perform a differential diagnosis based on morphological and clinical features - therefore it is only possible by accurate histology. Methods. The authors have retrospectively analysed clinical records of 240 patients who were affected by metatypical skin cancer and who were treated by surgery, radiotherapy and chemotherapy. Results. MTC affected more males than females (62.5% vs 37.5%) than males. The most affected site was the cervicofacial area, 71.7%; then the trunk, 10%; the limbs, 9.6%; the scalp 3.7%; and other regions 5%. A recurrence occurred in 24 cases (10%), mainly in head and neck area. Conclusion. In this manuscript, the authors have emphasised the importance of conducting a differential diagnosis, and the importance of the specific treatment for metatypical skin cancer, even though more clinical studies and long-term follow-ups are required before establishing specific guidelines. © 2008 Tarallo et al; licensee BioMed Central Ltd
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 19/02/2019
Archivio della ricerca- Università di Roma La Sapienza
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.uniroma1.it:11573/228...
Last time updated on 12/11/2016
Directory of Open Access Journals
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:doaj.org/article:ea2811985...
Last time updated on 17/12/2014
Springer - Publisher Connector
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 28/04/2017
IRIS - UNIRSM (Univ. degli Studi della Repubblica di San Marino)
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.unirsm.sm:20.500.1408...
Last time updated on 15/11/2024
Archivio della Ricerca - Università di Pisa
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:arpi.unipi.it:11568/852007
Last time updated on 10/08/2017